Discovery 1 X-MAN™
 |
| Discovery 1 lines encompass both ‘gain-of-function’ models generated via knock-in of mutated cancer genes and; ‘loss-of-function’ models generated via the knock-out of mutant alleles or tumor suppressor genes. The panel encompasses the primary patient genotypes known to be involved in the onset of most classes of human cancer. |
Horizon X-MAN Catalogue
Issue: Q4, 2011
Click here to view/download
Call us today on +44 (0) 1223 655580 or email us at xman@horizondiscovery.com to discuss how X-MAN products and services can target your specific research needs.
